Fighting Colorectal Cancer

Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in locally advanced hepatocellular carcinoma.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

A patient advocate says that patients with breast cancer may find it challenging to feel "normal," but reconstruction advancements may help.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

From the benefits of early adoption to the effectiveness of telehealth, here is what we reported about palliative care throughout the year.

Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors.